Complement Factor H or a related protein is produced by bladder tumors and is a marker for transitional cell carcinoma of the bladder.

被引：0
|
作者：
Kinders, RJ [1 ]
Kinders, R [1 ]
Enfield, DL [1 ]
Hass, GM [1 ]
机构：
[1] Bard Diagnost Sci Inc, Redmond, WA USA
来源：
CLINICAL CHEMISTRY | 1998年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
165
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [21] Polyomavirus infection as an early marker for bladder transitional cell carcinoma
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 118 - 118
  • [22] Polyomavirus infection as an early marker for bladder transitional cell carcinoma
    Gontero, P
    Omodeo-Zorini, E
    Cacciotti, P
    Sogni, F
    Kocjancic, E
    Frea, B
    Monga, G
    Gaudino, G
    JOURNAL OF UROLOGY, 2005, 173 (04): : 165 - 165
  • [23] Expression of lung resistance-related protein in transitional cell carcinoma of bladder
    Zhu, YY
    Kong, CZ
    Zeng, Y
    Sun, ZX
    Gao, H
    UROLOGY, 2004, 63 (04) : 694 - 698
  • [24] Human complement factor H related protein test for monitoring bladder cancer
    Raitanen, MP
    Marttila, T
    Nurmi, M
    Ala-Opas, M
    Nieminen, P
    Aine, R
    Tammela, TLJ
    Group, F
    JOURNAL OF UROLOGY, 2001, 165 (02): : 374 - 377
  • [25] Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder
    Heicappell, R
    Schostak, M
    Müller, M
    Miller, K
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (04): : 275 - 282
  • [26] Amplification/overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    de Pinieux, G
    Vincent-Salomon, A
    Couturier, J
    Beuzeboc, P
    Vicillefond, A
    Sastro-Gerau, X
    LABORATORY INVESTIGATION, 2001, 81 (01) : 106A - 106A
  • [27] Tissue polypeptide antigen discriminates between localised and disseminated transitional cell carcinoma of the bladder.
    William, K
    Arnberg, H
    Nilsson, S
    CLINICAL CHEMISTRY, 1997, 43 : 591 - 591
  • [28] Amplification/overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    de Pinieux, G
    Vincent-Salomon, A
    Couturier, J
    Beuzeboc, P
    Vieillefond, A
    Sastro-Garau, X
    MODERN PATHOLOGY, 2001, 14 (01) : 106A - 106A
  • [29] Prognostic significance of topoisomerase II alpha overexpression in transitional cell carcinoma of the urinary bladder.
    Graber, MW
    Abrahams, HM
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 96A - 96A
  • [30] Safety and tolerability of oral halofuginone hydrobromide in refractory recurrent transitional cell carcinoma of the bladder.
    Nativ, O
    Thorpe, A
    Laufer, M
    Matzkin, H
    Salzberg, M
    Yarkoni, S
    Dezube, B
    Harris, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 445S - 445S
12345